Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene ...
Pharmaceutical Technology on MSN
Alternative commercialisation models offer lifeline to future of gene therapies
Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy commercialisation models in the future.
In a CiOL interaction, Superteams.ai Founder Soum Paul breaks down enterprise AI adoption, fractional AI teams, governance ...
Andre Gelfi, IBJR Andre Gelfi, a board member and co-founder of the Brazilian Institute for Responsible Gaming (IBJR).
We’ve all seen it. The “Frankenstein UI.” You grab a “home” icon from one open-source set, a “settings” cog from a different ...
Explore how AI-driven anomaly detection enhances the security of Model Context Protocol (MCP) deployments, protecting AI infrastructure from evolving threats with real-time insights.
Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...
The National Medical Commission (NMC) has released the official NEET UG 2026 syllabus, outlining the topics to be covered in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback